[Articles] Completion axillary lymph node dissection for the identification of pN2–3 status as an indication for adjuvant CDK4/6 inhibitor treatment: a post-hoc analysis of the randomised, phase 3 SENOMAC trial

Related Posts

• [Comment] Time to abandon axillary lymph node dissection in early-stage breast cancer

  Over the past 50 years, the management of the axilla has drastically shifted towards less…

• [Articles] Artificial intelligence-based model for lymph node metastases detection on whole slide images in bladder cancer: a retrospective, multicentre, diagnostic study

  We developed an AI-based diagnostic model that did well in detecting lymph node metastases, particularly…

• [Articles] Concurrent chemoradiotherapy followed by adjuvant cisplatin–gemcitabine versus cisplatin–fluorouracil chemotherapy for N2–3 nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial

  Our findings suggest that concurrent adjuvant cisplatin–gemcitabine could be used as an adjuvant therapy in…